HomeCompareSBGOF vs MRK

SBGOF vs MRK: Dividend Comparison 2026

SBGOF yields 4.39% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SBGOF wins by $2973.79M in total portfolio value
10 years
SBGOF
SBGOF
● Live price
4.39%
Share price
$19.40
Annual div
$0.85
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$2973.85M
Annual income
$2,849,084,593.31
Full SBGOF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — SBGOF vs MRK

📍 SBGOF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSBGOFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SBGOF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SBGOF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SBGOF
Annual income on $10K today (after 15% tax)
$372.89/yr
After 10yr DRIP, annual income (after tax)
$2,421,721,904.31/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, SBGOF beats the other by $2,421,713,575.90/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SBGOF + MRK for your $10,000?

SBGOF: 50%MRK: 50%
100% MRK50/50100% SBGOF
Portfolio after 10yr
$1486.95M
Annual income
$1,424,547,195.72/yr
Blended yield
95.80%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

SBGOF
No analyst data
Altman Z
0.4
Piotroski
7/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SBGOF buys
0
MRK buys
8
PoliticianChamberTickerTypeAmountDate
Josh Gottheimer🏢 House$MRK▲ Buy$1,001 - $15,0002026-02-04
Michael McCaul🏢 House$MRK▼ Sell$15,001 - $50,0002026-01-13
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-12-19
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-12-18
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-11-13
Ro Khanna🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-29
Val Hoyle🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-23
Marjorie Taylor Greene🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-28
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-08-14
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-05
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSBGOFMRK
Forward yield4.39%2.76%
Annual dividend / share$0.85$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%32.7%
Portfolio after 10y$2973.85M$56.8K
Annual income after 10y$2,849,084,593.31$9,798.13
Total dividends collected$2965.00M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: SBGOF vs MRK ($10,000, DRIP)

YearSBGOF PortfolioSBGOF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$11,577$877.38$11,206$366.19+$371.00SBGOF
2$14,286$1,898.65$12,650$502.35+$1.6KSBGOF
3$19,666$4,379.30$14,407$694.19+$5.3KSBGOF
4$32,310$11,267.79$16,585$967.82+$15.7KSBGOF
5$69,175$34,602.94$19,342$1,363.89+$49.8KSBGOF
6$212,491$138,473.86$22,913$1,947.19+$189.6KSBGOF
7$1,022,437$795,071.55$27,662$2,823.89+$994.8KSBGOF
8$8,244,706$7,150,698.61$34,159$4,173.35+$8.21MSBGOF
9$116,600,641$107,778,805.43$43,337$6,308.80+$116.56MSBGOF
10$2,973,847,279$2,849,084,593.31$56,776$9,798.13+$2973.79MSBGOF

SBGOF vs MRK: Complete Analysis 2026

SBGOFStock

Standard Bank Group Limited provides banking and financial products and services in Africa and internationally. The company's personal banking products include bank accounts, digital wallets, credit and prepaid cards, saving and investment products, and foreign exchange products and services; home, personal, vehicle, and student loans; financial planning and trading services; and wills, estate, and trust services, as well as car, home, income, debt, funeral, life, travel, legal assist, and personal accident insurance. Its business banking products comprise business and attorney trust accounts; business, vehicle and asset finance, commercial property financing, and specialized financing; savings and investment accounts; business, loans, corporate risks, agri business, vehicle, commercial property, engineering risks, new contracts, cargo, cash, events, directors and officers liability, and commercial cyber insurance services; fleet management, merchant, cash, debit order, franchising, and ecommerce solutions; and employer value banking, instant money bulk and salary payments, pay and incentive cards, incentive cards, financial planning, and payroll and HR services. The company also provides trading and risk management solutions across financial markets, including foreign exchange, money markets, interest rates, equities, and credit and commodities; international trade finance, working capital, and investor service solutions. In addition, it offers wealth management products and services; and online, mobile, and telephone banking services. It serves small- and medium-sized businesses, large commercial enterprises, larger companies, governments, parastatals, and institutional clients. Standard Bank Group Limited was founded in 1862 and is based in Johannesburg, South Africa.

Full SBGOF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this SBGOF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SBGOF vs SCHDSBGOF vs JEPISBGOF vs OSBGOF vs KOSBGOF vs MAINSBGOF vs JNJSBGOF vs ABBVSBGOF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.